Caption Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$108K Buy
+14,400
New +$146K ﹤0.01% 1627
2025
Q4
– Sell
-4,123
Closed -$51.4K – 1992
2025
Q3
$39.8K Buy
+4,123
New +$36.5K ﹤0.01% 1573
2024
Q1
– Sell
-1,682
Closed -$29.9K – 1611
2023
Q4
$30.2K Buy
+1,682
New +$29.6K ﹤0.01% 1243
2023
Q2
– Sell
-5,804
Closed -$110K – 1354
2023
Q1
$110K Hold
5,804
– – ﹤0.01% 965
2022
Q4
$132K Buy
+5,804
New +$131K ﹤0.01% 1109
2022
Q3
– Sell
-8,700
Closed -$258K – 1792
2022
Q2
$215K Buy
+8,700
New +$217K ﹤0.01% 1223
2021
Q4
– Sell
-5,000
Closed -$170K – 1884
2021
Q3
$210K Buy
+5,000
New +$180K ﹤0.01% 1338
2021
Q2
– Sell
-16
Closed -$572 – 1523
2021
Q1
$1K Buy
+16
New +$682 ﹤0.01% 991
2020
Q4
– Sell
-10,500
Closed -$367K – 1205
2020
Q3
$289K Buy
+10,500
New +$342K 0.01% 859

Other funds holding RGNX

Caption Management's RGNX Position: Q3 2026 in Review

Caption Management opened a new position in Regenxbio (RGNX) in Q3 2026: 14,400 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings. This is a return to the name: Caption Management previously reported a position in RGNX as recently as Q3 2025.

Caption Management first reported a position in RGNX in Q3 2020 and has held it in 9 quarters since. The position peaked at $289K in Q3 2020. 174 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • Caption Management held 14,400 shares of Regenxbio worth $108K as of Q3 2026.
  • Regenxbio was a new Caption Management position in Q3 2026.
  • Regenxbio made up ﹤0.01% of Caption Management's portfolio in Q3 2026, its #1627 holding.
  • Caption Management first reported a position in Regenxbio in Q3 2020 and has held it in 9 quarters since.
  • Caption Management's Regenxbio position peaked at $289K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.